Skin Pharmacology and Physiology · 2010 · 14 citations · 37 references
Life SciencesBiochemistryGeneticsEnzymologyMetabolismPathophysiologyHeme MetabolismMetabolic Pathway DefectsMetabolic Pathway ElucidationPorphyrin MetabolismAnimal Disease ModelsEnzyme Replacement TherapyGene-targeted TherapyHeme Biosynthesis DisordersMetabolic PorphyriasPorphyria PathobiologyPorphyrin Pathway EnzymesTreatment Strategies
The porphyrias are clinically and genetically heterogeneous metabolic disorders resulting from a predominantly hereditary dysfunction of specific enzymes involved in heme biosynthesis. Today, the clinical, biochemical, and genetic characteristics of this fascinating group of diseases are well established. Recently, different in vitro and animal models have facilitated the investigation of etiopathologic mechanisms in the different types of porphyria and the development of causal treatment strategies such as pathway interference, enzyme replacement, and gene therapy. The continuous progress in basic science has made an invaluable contribution to the rapid translation of discoveries made in the laboratory into new diagnostics and therapeutics in the near future.
37
Liver transplantation as a cure for acute intermittent porphyria
Zahir Soonawalla, Taner Oruğ, Michael N. Badminton et al. · The Lancet · 2004 · 194 citations
Liver transplantation for erythropoietic protoporphyria liver disease
Brendan M. McGuire, Herbert L. Bonkovsky, Robert L. Carithers et al. · Liver Transplantation · 2005 · 162 citations · Full text
Medicine, Hematology, Surgery +17
A zebrafish model for hepatoerythropoietic porphyria
Han Wang, Qiaoming Long, Scott D. Marty et al. · Nature Genetics · 1998 · 146 citations
Acute hepatic porphyria and hepatocellular carcinoma
Raili Kauppinen, P Mustajoki · British Journal of Cancer · 1988 · 131 citations · Full text